They demonstrated that many identified GWAS risk genes (CARD9, CDH1, ICAM3 etc.)presented different methylation status between IBD patients (CD and UC) and healthy controls, suggesting a possibility of mechanistic interactions between the epigenetic and genetic signals. This evidence concerns the gene CDH1 and inflammatory bowel disease.